BridgeBio Pharma, Inc.: Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
BridgeBio Pharma, Inc.: Acoramidis Shows Statistically Significant Im…
Mar 31, 2025
finanznachrichten.de
Acoramidis: A Potential Breakthrough Treatment for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) | Cardiology
Acoramidis: A Potential Breakthrough Treatment for Trans…
Jul 18, 2023
labroots.com
BridgeBio Pharma, Inc.: BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
BridgeBio Pharma, Inc.: BridgeBio Pharma Announces U.S. Food an…
May 2, 2024
finanznachrichten.de
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the First Near Complete TTR Stabilizer (=90%), Approved by the European Commission to Treat ATTR-CM
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the Fir…
6 months ago
finanznachrichten.de
BridgeBio Pharma Reports Phase 3 Data Linking TTR Increase to Improved Survival With Acoramidis
BridgeBio Pharma Reports Phase 3 Data Linking TTR Increase to Impr…
11 months ago
marketscreener.com
BridgeBio Pharma Announces Long-Term Efficacy And Safety Data For Acoramidis In Patients With ATTR-CM
BridgeBio Pharma Announces Long-Term Efficacy And Safety D…
1 month ago
marketscreener.com
BridgeBio Pharma, Inc.: BridgeBio Announces Commercial Progress, Program Updates, and 2025 Milestones
BridgeBio Pharma, Inc.: BridgeBio Announces Commercial Progress…
Jan 13, 2025
finanznachrichten.de
This Biotech Is On A Triple-Digit Run, And Shows No Signs Of Slo…
5 months ago
investors.com
Un dirigeant de Bridgebio Pharma cède des actions pour 5,9 million…
5 months ago
zonebourse.com
2:48
BridgeBio CEO Neil Kumar: Our heart disease drug staves off deat…
1.5K viewsJan 14, 2025
YouTubeCNBC Television
Hedge Funds Are Nibbling On BridgeBio Pharma, Inc. (BBIO)
Jul 5, 2020
insidermonkey.com
Prediction: BridgeBio Pharma Will Beat the Market. Here's Why | The …
Mar 4, 2025
fool.com
BridgeBio Pharma, Inc.: BridgeBio Announces Infigratinib Is the Firs…
Sep 17, 2024
finanznachrichten.de
Transcript : BridgeBio Pharma, Inc., Q2 2025 Earnings Call, Aug 05, 2025
9 months ago
zonebourse.com
BridgeBio's Most 'Hotly Debated' Drug Scores Big In Phase 3
2 months ago
investors.com
1:49
BridgeBio Raised $135M to Fund 10 Drugs at Once—Here’s How
144 views9 months ago
YouTubeMelissa Bime
BridgeBio Pharma: ATTRibute-CM Study Fails To Meet Primary Endp…
Dec 27, 2021
nasdaq.com
19:42
罕見疾病新星爆發！BridgeBio (BBIO) 三大新藥報捷，單挑輝瑞巨頭，20…
23 views2 months ago
YouTube來聽美股吧
7:33
罕見疾病新星爆發！BridgeBio (BBIO) 三大新藥報捷，單挑輝瑞巨頭，20…
39 views2 months ago
YouTube來聽美股吧
16:33
유전적 타겟과 금융적 창의성: 브릿지바이오(BBIO)의 지속 가능한 …
1 month ago
YouTubeBIOINTEL_PINNACLE
BridgeBio LLC
Nov 30, 2017
biospace.com
1:01:15
Founder Stories: Neil Kumar - founder and CEO of BridgeBio
2.8K viewsJun 14, 2020
YouTubeAxial
1:52
How BridgeBio Transformed Compliance With Egnyte’s GxP Co…
124 viewsApr 30, 2025
YouTubeEgnyte
1:01
BridgeBio gains on phase 3 dwarfism data #pharma #pharman…
74 views2 months ago
YouTubepharmaphorum media limited
10:36
Exclusive Insights: Neil Kumar on Bridge Biopharma's Global Missio…
480 viewsMar 29, 2024
YouTubeIndo US Organization for Rare Diseases
37:34
BridgeBio Pharma (BBIO) @ JPM 2026 第44届摩根大通医疗保健会议
7 views3 months ago
bilibilibili_42520431755
LLNL and BridgeBio announce trials for supercomputing-discovered ca…
2 months ago
llnl.gov
6:48
Dwarfism meds took kids who started at a low growth baseline t…
2 months ago
Fox Business
8:32
Putting Patients First: BridgeBio Founder & CEO, Neil Kumar, Ph.D…
917 views11 months ago
YouTubeBridgeBio
1:14
AT&T downgrade, BridgeBio Pharma's heart treatment, PepsiC…
Jul 17, 2023
Yahoo
See more videos
Static thumbnail place holder